The neutrophil-to-lymphocyte ratio in complete blood cell count may be an available marker for active adult-onset Still's disease

In clinical practice, acute-phase protein measurements during inflammation are usually used to monitor the activity and severity of adult-onset Still's disease (AOSD).Objective: to study the possibility of using the neutrophil-to-lymphocyte ratio (NLR) in complete blood cell count as a marker f...

Full description

Bibliographic Details
Main Authors: Yu. V. Muravyev, V. V. Lebedeva, S. I. Glukhova
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2020-11-01
Series:Современная ревматология
Subjects:
Online Access:https://mrj.ima-press.net/mrj/article/view/1070
_version_ 1826556823236247552
author Yu. V. Muravyev
V. V. Lebedeva
S. I. Glukhova
author_facet Yu. V. Muravyev
V. V. Lebedeva
S. I. Glukhova
author_sort Yu. V. Muravyev
collection DOAJ
description In clinical practice, acute-phase protein measurements during inflammation are usually used to monitor the activity and severity of adult-onset Still's disease (AOSD).Objective: to study the possibility of using the neutrophil-to-lymphocyte ratio (NLR) in complete blood cell count as a marker for the activity and severity of AOSD in clinical practice.Patients and methods. The investigation enrolled 48 patients (29 females and 19 males; mean age, 32.8±12.5 years) with active AOSD, who met the criteria devised by M. Yamaguchi et al. Along with standard clinical and laboratory parameters and systemic scores, NLR was calculated in complete blood cell count.Results and discussion. There was a statistically significant correlation of NLR with the level of CRP (r=0.532), ferritin (r=0.43), ESR (r=0.40), and the systemic score reflecting the severity of the disease (r=0.449), which allows NLR to be regarded as a tool that is convenient to assess the activity and severity of AOSD in clinical practice.Conclusion. The findings have shown the good sensitivity and specificity of NLR, which indicates the possibility of using the latter as an available marker for assessing the activity and severity of AOSD in clinical practice.
first_indexed 2024-04-10T02:06:02Z
format Article
id doaj.art-1ae7ab77593245cf829b75df5e641f7f
institution Directory Open Access Journal
issn 1996-7012
2310-158X
language Russian
last_indexed 2025-03-14T08:18:49Z
publishDate 2020-11-01
publisher IMA-PRESS LLC
record_format Article
series Современная ревматология
spelling doaj.art-1ae7ab77593245cf829b75df5e641f7f2025-03-02T13:11:03ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2020-11-01144656910.14412/1996-7012-2020-4-65-692298The neutrophil-to-lymphocyte ratio in complete blood cell count may be an available marker for active adult-onset Still's diseaseYu. V. Muravyev0V. V. Lebedeva1S. I. Glukhova2V.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyIn clinical practice, acute-phase protein measurements during inflammation are usually used to monitor the activity and severity of adult-onset Still's disease (AOSD).Objective: to study the possibility of using the neutrophil-to-lymphocyte ratio (NLR) in complete blood cell count as a marker for the activity and severity of AOSD in clinical practice.Patients and methods. The investigation enrolled 48 patients (29 females and 19 males; mean age, 32.8±12.5 years) with active AOSD, who met the criteria devised by M. Yamaguchi et al. Along with standard clinical and laboratory parameters and systemic scores, NLR was calculated in complete blood cell count.Results and discussion. There was a statistically significant correlation of NLR with the level of CRP (r=0.532), ferritin (r=0.43), ESR (r=0.40), and the systemic score reflecting the severity of the disease (r=0.449), which allows NLR to be regarded as a tool that is convenient to assess the activity and severity of AOSD in clinical practice.Conclusion. The findings have shown the good sensitivity and specificity of NLR, which indicates the possibility of using the latter as an available marker for assessing the activity and severity of AOSD in clinical practice.https://mrj.ima-press.net/mrj/article/view/1070adult-onset still's diseaseneutrophil-to-lymphocyte ratioferritinc-reactive proteinerythrocyte sedimentation rate
spellingShingle Yu. V. Muravyev
V. V. Lebedeva
S. I. Glukhova
The neutrophil-to-lymphocyte ratio in complete blood cell count may be an available marker for active adult-onset Still's disease
Современная ревматология
adult-onset still's disease
neutrophil-to-lymphocyte ratio
ferritin
c-reactive protein
erythrocyte sedimentation rate
title The neutrophil-to-lymphocyte ratio in complete blood cell count may be an available marker for active adult-onset Still's disease
title_full The neutrophil-to-lymphocyte ratio in complete blood cell count may be an available marker for active adult-onset Still's disease
title_fullStr The neutrophil-to-lymphocyte ratio in complete blood cell count may be an available marker for active adult-onset Still's disease
title_full_unstemmed The neutrophil-to-lymphocyte ratio in complete blood cell count may be an available marker for active adult-onset Still's disease
title_short The neutrophil-to-lymphocyte ratio in complete blood cell count may be an available marker for active adult-onset Still's disease
title_sort neutrophil to lymphocyte ratio in complete blood cell count may be an available marker for active adult onset still s disease
topic adult-onset still's disease
neutrophil-to-lymphocyte ratio
ferritin
c-reactive protein
erythrocyte sedimentation rate
url https://mrj.ima-press.net/mrj/article/view/1070
work_keys_str_mv AT yuvmuravyev theneutrophiltolymphocyteratioincompletebloodcellcountmaybeanavailablemarkerforactiveadultonsetstillsdisease
AT vvlebedeva theneutrophiltolymphocyteratioincompletebloodcellcountmaybeanavailablemarkerforactiveadultonsetstillsdisease
AT siglukhova theneutrophiltolymphocyteratioincompletebloodcellcountmaybeanavailablemarkerforactiveadultonsetstillsdisease
AT yuvmuravyev neutrophiltolymphocyteratioincompletebloodcellcountmaybeanavailablemarkerforactiveadultonsetstillsdisease
AT vvlebedeva neutrophiltolymphocyteratioincompletebloodcellcountmaybeanavailablemarkerforactiveadultonsetstillsdisease
AT siglukhova neutrophiltolymphocyteratioincompletebloodcellcountmaybeanavailablemarkerforactiveadultonsetstillsdisease